| Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference H Northrup, DA Krueger, S Roberds, K Smith, J Sampson, B Korf, ... Pediatric neurology 49 (4), 243-254, 2013 | 1688 | 2013 |
| Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference DA Krueger, H Northrup, S Roberds, K Smith, J Sampson, B Korf, ... Pediatric neurology 49 (4), 255-265, 2013 | 951 | 2013 |
| Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations H Northrup, ME Aronow, EM Bebin, J Bissler, TN Darling, PJ de Vries, ... Pediatric Neurology 123, 50-66, 2021 | 508 | 2021 |
| The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial AL Lux, SW Edwards, E Hancock, AL Johnson, CR Kennedy, RW Newton, ... The Lancet 364 (9447), 1773-1778, 2004 | 443 | 2004 |
| Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study AA Mallick, V Ganesan, FJ Kirkham, P Fallon, T Hedderly, T McShane, ... The Lancet Neurology 13 (1), 35-43, 2014 | 434 | 2014 |
| The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised … AL Lux, SW Edwards, E Hancock, AL Johnson, CR Kennedy, RW Newton, ... The Lancet Neurology 4 (11), 712-717, 2005 | 427 | 2005 |
| Critical periods of brain growth and cognitive function in children CR Gale, FJ O’Callaghan, KM Godfrey, CM Law, CN Martyn Brain 127 (2), 321-329, 2004 | 379 | 2004 |
| Prevalence of tuberous sclerosis estimated by capture-recapture analysis FJK O'Callaghan, AW Shiell, JP Osborne, CN Martyn The Lancet 351 (9114), 1490, 1998 | 372 | 1998 |
| Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex C Joinson, FJ O'CALLAGHAN, JP Osborne, C Martyn, T Harris, PF Bolton Psychological medicine 33 (2), 335-344, 2003 | 363 | 2003 |
| The influence of head growth in fetal life, infancy, and childhood on intelligence at the ages of 4 and 8 years CR Gale, FJ O'Callaghan, M Bredow, CN Martyn, ... Pediatrics 118 (4), 1486-1492, 2006 | 345 | 2006 |
| Ophthalmic manifestations of tuberous sclerosis: a population based study SA Rowley, FJ O'callaghan, JP Osborne British Journal of Ophthalmology 85 (4), 420-423, 2001 | 308 | 2001 |
| The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study FJK O’Callaghan, AL Lux, K Darke, SW Edwards, E Hancock, AL Johnson, ... Epilepsia 52 (7), 1359-1364, 2011 | 294 | 2011 |
| The underlying etiology of infantile spasms (West syndrome): Information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification 2 JP Osborne, AL Lux, SW Edwards, E Hancock, AL Johnson, CR Kennedy, ... Epilepsia 51 (10), 2168-2174, 2010 | 292 | 2010 |
| Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial FJK O'Callaghan, SW Edwards, FD Alber, E Hancock, AL Johnson, ... The Lancet Neurology 16 (1), 33-42, 2017 | 289 | 2017 |
| The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex FJK O’Callaghan, T Harris, C Joinson, P Bolton, M Noakes, D Presdee, ... Archives of disease in childhood 89 (6), 530-533, 2004 | 255 | 2004 |
| CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients HL Archer, J Evans, S Edwards, J Colley, R Newbury-Ecob, ... Journal of medical genetics 43 (9), 729-734, 2006 | 252 | 2006 |
| An epidemiological study of renal pathology in tuberous sclerosis complex FJ O'Callaghan, MJ Noakes, CN Martyn, JP Osborne BJU international 94 (6), 853-857, 2004 | 252 | 2004 |
| TuberOus SClerosis registry to increase disease Awareness (TOSCA)–baseline data on 2093 patients JC Kingswood, GB d’Augères, E Belousova, JC Ferreira, T Carter, ... Orphanet journal of rare diseases 12, 1-13, 2017 | 246 | 2017 |
| Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial EA Thiele, EM Bebin, H Bhathal, FE Jansen, K Kotulska, JA Lawson, ... JAMA neurology 78 (3), 285-292, 2021 | 232 | 2021 |
| Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study MA Kurian, Y Li, J Zhen, E Meyer, N Hai, HJ Christen, GF Hoffmann, ... The Lancet Neurology 10 (1), 54-62, 2011 | 220 | 2011 |